Clinical trial registry record

Glycine Supplementation Improves Cognitive Performance in Mexican Older Adults

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated June 15, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07643675
Last registry update
June 15, 2026
Status
Completed
Phase
Phase not reported
Sponsor
Brenda Sarahí Beristain Lujano
Enrollment
59
Countries
Mexico
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · SUPPORTIVE CARE · NONE
Evidence population
Human clinical study registration
Participants
59
Population
ALL · 60 Years to 80 Years
Duration
2024-12-01 to 2025-12-01
Intervention
Glycine
Comparator
Not reported
Outcomes measured
Brain-Derived Neurotrophic Factor (BDNF) levels — Baseline (T0), 3 months (T3) and 6 months (T6); Cognitive performance evaluated by the Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Glycine and GlyNAC · 100%Title contains controlled term: glycine. Abstract contains controlled term: glycine. Source terminology contains: glycine. Title supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

glycine glynac
Open primary sourceExport JSON